Validea Detailed Fundamental Analysis

Validea's guru fundamental report indicates that Johnson & Johnson (JNJ) receives a high rating (88%) based on their P/B Growth Investor model, which is based on the strategy of Partha Mohanram, signaling strong interest in the stock based on underlying fundamentals and valuation; the model favors low book-to-market stocks exhibiting sustained future growth, with JNJ passing most of the model's tests except for the research and development to assets ratio.

Analysis

Johnson & Johnson (JNJ) has received a high rating of 88% from Validea's P/B Growth Investor model, which is based on the published strategy of Partha Mohanram. This model specifically targets low book-to-market stocks demonstrating characteristics associated with sustained future growth, and an 88% score signifies considerable interest from this strategy, nearing the 90% threshold for strong interest. As a large-cap growth stock in the Biotechnology & Drugs industry, JNJ passed crucial fundamental tests within this model, including Book/Market Ratio, Return on Assets, Cash Flow from Operations to Assets, the ratio of Cash Flow from Operations to Assets versus Return on Assets, Return on Assets Variance, Sales Variance, Advertising to Assets, and Capital Expenditures to Assets. The singular criterion JNJ failed to meet was Research and Development to Assets. This comprehensive positive assessment, barring the R&D metric, underscores JNJ's strong underlying fundamentals and favorable valuation from the perspective of this specific growth investment strategy.

Key Decisions for Investors

• Investors employing growth-focused strategies may consider JNJ a compelling opportunity, given its high score on a model designed to identify stocks with sustained future growth potential.
• The strong performance across multiple fundamental metrics, particularly return on assets and cash flow generation, supports a constructive view, although the flagged Research and Development to Assets ratio should be monitored as a potential factor influencing long-term innovation capabilities.
• Given the strategy's emphasis on sustained growth and JNJ's classification as a large-cap growth stock, any investment consideration should align with a long-term outlook.